Time's up: mutation rate and lifespan
Signal Transduct Target Ther
.
2022 Aug 12;7(1):282.
doi: 10.1038/s41392-022-01122-8.
Authors
Anjali Cremer
1
2
3
,
Wesley T Abplanalp
#
4
5
6
7
,
Michael A Rieger
#
8
9
10
11
Affiliations
1
Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, Frankfurt am Main, Germany.
2
Frankfurt Cancer Institute, Frankfurt am Main, Germany.
3
German Cancer Consortium (DKTK) and German Cancer Research Center (DKTK), Heidelberg, Germany.
4
Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Goethe University Frankfurt, Frankfurt am Main, Germany.
5
German Center for Cardiovascular Research DZHK, Partner site Frankfurt Rhine-Main, Berlin, Germany.
6
Cardiopulmonary Institute, Goethe University Frankfurt, Frankfurt, Germany.
7
EnABLE Consortium, Goethe University Frankfurt, Frankfurt, Germany.
8
Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, Frankfurt am Main, Germany. m.rieger@em.uni-frankfurt.de.
9
Frankfurt Cancer Institute, Frankfurt am Main, Germany. m.rieger@em.uni-frankfurt.de.
10
German Cancer Consortium (DKTK) and German Cancer Research Center (DKTK), Heidelberg, Germany. m.rieger@em.uni-frankfurt.de.
11
Cardiopulmonary Institute, Goethe University Frankfurt, Frankfurt, Germany. m.rieger@em.uni-frankfurt.de.
#
Contributed equally.
PMID:
35961971
PMCID:
PMC9374720
DOI:
10.1038/s41392-022-01122-8
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Longevity* / genetics
Mutation Rate*